The antibody response to the Plasmodium falciparum major merozoite surface antigen (gp195) of congenic mouse strains differing in H-2 haplotype has been examined. AU seven strains of mice were capable of producing gp195-specific antibodies. Generalized immune recognition of gp195 by mice of diverse H-2 haplotypes distinguished gp195 from the P. falciparum circumsporozoite protein and the 230-kDa and 48/45-kDa gamete surface antigens. However, the H-2 genetic locus appeared to influence the specificity of gp195-speciflic antibodies. Immunoblot patterns of mouse sera with parasite antigens revealed a complex pattern of reactivity with terminal and intermediate processing fragments of gp195. The majority of immunoblot bands observed were similar for all of the mouse strains; however, there were several strains that additionally recognized a few unique fragments or displayed more intense reactivities with specific processing fragments. These results suggest that while individuals of diverse major histocompatibility complex makeup are capable of recognizing the gp195 antigen, the recognition of specific gp195B-cell and T-cell epitopes may be under control of the major histocompatibility complex.The global resurgence of malaria, which is due in part to the spread of drug-resistant Plasmodium falciparum and the reduced efficacy of vector control measures, has intensified efforts to develop a malaria vaccine (1, 2). The current subunit vaccine strategy for producing a malaria vaccine relies on the ability of single parasite antigens to confer protective immunity in animal models or to induce antibodies that inhibit parasite growth in vitro (3). Antigens expressed during several stages of the complex life cycle of P. In toto, these results have profound implications for development of subunit malaria vaccines. In order to be effective, a vaccine must stimulate an immune response in individuals of diverse genetic makeup. If widespread, genetically controlled nonresponsiveness is a common characteristic of malaria antigens, the feasibility of the subunit vaccine strategy will be severely compromised.While genetic control of immune responsiveness to certain malaria antigens of the sexual stages of the parasite life cycle has been demonstrated, the effect of major histocompatibility complex (MHC) genes on responsiveness to asexual bloodstage antigens has not been examined. A prime candidate antigen for the development ofimmunity to the asexual blood stages ofP. falciparum is the major merozoite surface protein (gp195), whose processing fragments are found on the surface of the infective merozoite (9). Several laboratories including our own have shown that vaccination of monkeys with purified gp195 or its processing fragments protects these animals against a lethal challenge dose of P. falciparum (10)(11)(12)(13). In addition, a limited clinical trial with synthetic peptides containing gp195-related amino acid sequences has produced promising results (14). Therefore, it is important to determine whether immune respons...